Literature DB >> 28062393

Proportion of Tubal Factor Infertility due to Chlamydia: Finite Mixture Modeling of Serum Antibody Titers.

A E Ades, M J Price, D Kounali, V A Akande, G S Wills, M O McClure, P Muir, P J Horner.   

Abstract

In this study, we examined whether the proportion of tubal factor infertility (TFI) that is attributable to Chlamydia trachomatis, the population excess fraction (PEF), can be estimated from serological data using finite mixture modeling. Whole-cell inclusion immunofluorescence serum antibody titers were recorded among infertile women seen at St. Michael's Hospital in Bristol, United Kingdom, during the period 1985-1995. Women were classified as TFI cases or controls based on laparoscopic examination. Finite mixture models were used to identify the number of component titer distributions and the proportion of serum samples in each, from which estimates of PEF were derived. Four titer distributions were identified. The component at the highest titer was found only in samples from women with TFI, but there was also an excess of the second-highest titer component in TFI cases. Minimum and maximum estimates of the PEF were 28.0% (95% credible interval: 6.9, 50.0) and 46.8% (95% credible interval: 23.2, 64.1). Equivalent estimates based on the standard PEF formula from case-control studies were 0% and over 65%. Finite mixture modeling can be applied to serological data to obtain estimates of the proportion of reproductive damage attributable to C. trachomatis Further studies using modern assays in contemporary, representative populations should be undertaken.
© The Author 2017. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Chlamydia trachomatis; antibody titers; finite mixture models; population excess fraction; tubal factor infertility

Mesh:

Substances:

Year:  2017        PMID: 28062393     DOI: 10.1093/aje/kww117

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

Review 1.  Advancing the public health applications of Chlamydia trachomatis serology.

Authors:  Sarah C Woodhall; Rachel J Gorwitz; Stephanie J Migchelsen; Sami L Gottlieb; Patrick J Horner; William M Geisler; Catherine Winstanley; Katrin Hufnagel; Tim Waterboer; Diana L Martin; Wilhelmina M Huston; Charlotte A Gaydos; Carolyn Deal; Magnus Unemo; J Kevin Dunbar; Kyle Bernstein
Journal:  Lancet Infect Dis       Date:  2018-07-05       Impact factor: 25.071

Review 2.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

Review 3.  What Can Serology Tell Us About the Burden of Infertility in Women Caused by Chlamydia?

Authors:  Patrick J Horner; Gloria E Anyalechi; William M Geisler
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 5.226

4.  High Plasmid Gene Protein 3 (Pgp3) Chlamydia trachomatis Seropositivity, Pelvic Inflammatory Disease, and Infertility Among Women, National Health and Nutrition Examination Survey, United States, 2013-2016.

Authors:  Gloria E Anyalechi; Jaeyoung Hong; Damien C Danavall; Diana L Martin; Sarah E Gwyn; Patrick J Horner; Brian H Raphael; Robert D Kirkcaldy; Ellen N Kersh; Kyle T Bernstein
Journal:  Clin Infect Dis       Date:  2021-10-20       Impact factor: 20.999

5.  Evaluation of a PGP3 ELISA for surveillance of the burden of Chlamydia infection in women from Australia and Samoa.

Authors:  Rami Mazraani; Peter Timms; Philip C Hill; Tamaailau Suaalii-Sauni; Tavita Niupulusu; Seiuli V A Temese; Liai Iosefa-Siitia; Leveti Auvaa; Siuomatautu A Tapelu; Maauga F Motu; Antoinette Righarts; Michael S Walsh; Luk Rombauts; John A Allan; Patrick Horner; Wilhelmina M Huston
Journal:  Pathog Dis       Date:  2019-04-01       Impact factor: 3.166

6.  Estimating prevalence from dried blood spots without using biological cut-offs: application of a novel approach to hepatitis C virus in drug users in France (ANRS-Coquelicot survey).

Authors:  L Léon; J Pillonel; M Jauffret-Roustide; F Barin; Y Le Strat
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

7.  Management of chlamydia and gonorrhoea infections diagnosed in primary care using a centralised nurse-led telephone-based service: mixed methods evaluation.

Authors:  Jeremy Horwood; Emer Brangan; Petra Manley; Paddy Horner; Peter Muir; Paul North; John Macleod
Journal:  BMC Fam Pract       Date:  2020-12-10       Impact factor: 2.497

8.  Chlamydial Pgp3 Seropositivity and Population-Attributable Fraction Among Women With Tubal Factor Infertility.

Authors:  Gloria E Anyalechi; Jaeyoung Hong; Robert D Kirkcaldy; Harold C Wiesenfeld; Paddy Horner; Gillian S Wills; Myra O McClure; Karen R Hammond; Catherine L Haggerty; Dmitry M Kissin; Edward W Hook; Michael P Steinkampf; Kyle Bernstein; William M Geisler
Journal:  Sex Transm Dis       Date:  2021-03-31       Impact factor: 3.868

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.